Peripheral Neuropathy Trial, Recruiting NCT05172089 Sponsor: University of Pittsburgh Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT05172089
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a man or woman aged 18 or older
  • You are willing to follow all study instructions, attend all visits, and take part in all study activities
  • You have an open (not yet healed) foot ulcer related to diabetes
  • You have enough blood flow to the affected area, shown by at least one of several specific blood flow tests (confirm with trial site)

Who may not be able to join:

  • You are not able to understand what the study involves, including its risks and benefits
  • Your wound is already closed or is planned to be closed with a skin flap or skin graft surgery
  • You have a serious immune system condition, such as HIV/AIDS, or you take medications that weaken your immune system
  • Your blood flow test results show poor circulation below a certain level (confirm with trial site)
  • Your blood sugar control has been very poor — specifically, a blood test called HbA1c came back above 15 within the last 3 months
  • You have an autoimmune connective tissue disease (a condition where the immune system attacks the body's own tissues — confirm with trial site)
  • The size or location of your wound makes a specific skin measurement test impossible to carry out (confirm with trial site)
  • You are currently pregnant
  • You are currently in prison
  • You are unable to follow the study procedures or attend all required visits

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chandan K Sen, PhD, University of Pittsburgh

Phone: 4126240422

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 April 2024
Est. completion
27 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Biofilm infection abundance; TEWL

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov